About Sagimet Biosciences, Inc. 
Sagimet Biosciences, Inc.
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates 
No Company Details Available
Shareholding Snapshot
Shareholding Compare (%holding) 
Majority shareholders
Domestic Funds
Domestic Funds
Held in 23 Schemes (18.81%)
Foreign Institutions
Held by 33 Foreign Institutions (7.09%)
Strategic Entities with highest holding
Highest Public shareholder
Management
Designation
No Data
Revenue and Profits:
Net Sales:
(Quarterly Results - Jun 2025)
Net Profit:
-10 Million
Pharmaceuticals & Biotechnology
USD 197 Million ()
NA (Loss Making)
NA
0.00%
-0.98
-48.36%
1.65






